Health Canada
Is Cagrilintide (and CagriSema) legal in Canada?
Under reviewCagrilintide with semaglutide (CagriSema) under review since March 2026; no cagrilintide product is authorised
A regulator is actively reviewing it.
Health Canada's list of new drug submissions under review, current as of 2026-08-31, includes cagrilintide with semaglutide from Novo Nordisk Canada, accepted into review in 2026-03 as a new active substance. Cagrilintide is not in the Drug Product Database, so no cagrilintide product can be sold in Canada yet.
Last verified 2026-09-29 · how we verify
Cagrilintide (and CagriSema) elsewhere
Sources (2)
- 01Drug and Health Product Submissions Under Review: New drug submissions under review (list current as of 2026-08-31)Health Canada · 2026-08-31 · accessed 2026-09-29
- 02Drug Product Database API: active-ingredient search for cagrilintideHealth Canada (Drug Product Database) · 2026-09-29 · accessed 2026-09-29